Article Details

Targeting RNA splicing can activate antiviral immune pathways in triple negative breast cancers

Retrieved on: 2021-01-14 15:56:15

Tags for this article:

Click the tags to see associated articles and topics

Targeting RNA splicing can activate antiviral immune pathways in triple negative breast cancers. View article details on hiswai:

Excerpt

In this study, we discovered that these therapeutics are modulators of anti-tumor immunity," said Dr. Trey Westbrook, corresponding author of the study ...

Article found on: www.news-medical.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo